PG
CVS icon

PEAK6 Group’s CVS Health CVS Stock Holding History

PEAK6 Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$4.69M Buy
72,900
+62,900
+629% +$4.15M 0.02% 801
2018
Q1 		$622K Sell
10,000
-177,000
-95% -$12.7M ﹤0.01% 2379
2017
Q4 		$13.6M Sell
187,000
-144,800
-44% -$10.5M 0.06% 355
2017
Q3 		$27M Buy
331,800
+183,500
+124% +$14.5M 0.14% 140
2017
Q2 		$11.9M Buy
148,300
+108,900
+276% +$8.6M 0.07% 304
2017
Q1 		$3.09M Buy
39,400
+28,200
+252% +$2.25M 0.03% 831
2016
Q4 		$884K Sell
11,200
-69,400
-86% -$5.62M 0.01% 1986
2016
Q3 		$7.17M Buy
80,600
+24,700
+44% +$2.33M 0.05% 504
2016
Q2 		$5.35M Buy
55,900
+32,000
+134% +$3.19M 0.04% 633
2016
Q1 		$2.48M Sell
23,900
-111,600
-82% -$10.9M 0.02% 1036
2015
Q4 		$13.2M Buy
135,500
+67,600
+100% +$6.62M 0.09% 272
2015
Q3 		$6.55M Buy
67,900
+24,800
+58% +$2.61M 0.03% 712
2015
Q2 		$4.52M Sell
43,100
-26,100
-38% -$2.67M 0.03% 896
2015
Q1 		$7.14M Buy
69,200
+9,300
+16% +$941K 0.05% 485
2014
Q4 		$5.77M Buy
59,900
+55,700
+1,326% +$4.91M 0.04% 590
2014
Q3 		$334K Sell
4,200
-11,300
-73% -$891K ﹤0.01% 2841
2014
Q2 		$1.17M Sell
15,500
-5,700
-27% -$431K 0.01% 1513
2014
Q1 		$1.59M Sell
21,200
-8,300
-28% -$586K 0.01% 1454
2013
Q4 		$2.11M Sell
29,500
-180,100
-86% -$11.6M 0.01% 1408
2013
Q3 		$5.95M Sell
209,600
-17,900
-8% -$1.07M 0.04% 632
2013
Q2 		$13K Buy
+227,500
New +$13.2M 0.05% 222

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PEAK6 Group's CVS Position: Q2 2018 in Review

PEAK6 Group reduced its CVS Health (CVS) stake by 35% in Q2 2018, selling an estimated $4.92M and leaving 141,694 shares worth $9.12M. The position accounts for 0.04% of the portfolio, ranked #479.

PEAK6 Group first reported a position in CVS in Q4 2013 and has held it in 11 quarters since. The position peaked at $13.5M in Q1 2018. 1,572 funds tracked by Wall St. Rank hold CVS as of Q2 2018.

  • PEAK6 Group held 141,694 shares of CVS Health worth $9.12M as of Q2 2018.
  • PEAK6 Group sold 74,717 CVS Health shares in Q2 2018, an estimated $4.92M.
  • CVS Health made up 0.04% of PEAK6 Group's portfolio in Q2 2018, its #479 holding.
  • PEAK6 Group first reported a position in CVS Health in Q4 2013 and has held it in 11 quarters since.
  • PEAK6 Group's CVS Health position peaked at $13.5M in Q1 2018.
  • 1,572 funds tracked by Wall St. Rank held CVS Health as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.